Orphan Medicine Market Access in Europe: Growing Challenges Ahead?

Event Host

Event Description

Dr Paul Craddy and Dr Graham Foxon are delighted to present Remap Consulting’s newest webinar on orphan market access in Europe.

The session will include discussions on:

• How rare diseases will be impacted by the EU HTA.
• The impact of HUMN legislation on European market access.
• Comparing and contrasting different access strategies for orphan drugs.
• Parallel scientific advice.